PDS Biotechnology (Germany) Today
| EU6 Stock | EUR 1.58 0.05 3.07% |
Performance0 of 100
| Odds Of DistressOver 67
|
PDS Biotechnology is trading at 1.58 as of the 4th of January 2025. This is a 3.07% down since the beginning of the trading day. The stock's lowest day price was 1.57. PDS Biotechnology has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 10th of January 2024 and ending today, the 4th of January 2025. Click here to learn more.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. PDS BIOTECHNOLOGY operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. The company has 28.89 M outstanding shares. More on PDS Biotechnology Corp
Moving together with PDS Stock
| 0.76 | CSJA | CSL LTD SPONADR | PairCorr |
| 0.77 | CSJ | CSL Limited | PairCorr |
| 0.63 | MBG | Mercedes Benz Group | PairCorr |
| 0.81 | 0QF | Moderna | PairCorr |
Moving against PDS Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
PDS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PDS Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PDS Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Frank BeduAddo |
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotech, Biotechnology, Healthcare (View all Sectors) |
PDS Biotechnology Corp (EU6) is traded on Frankfurt Exchange in Germany and employs 22 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 206 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PDS Biotechnology's market, we take the total number of its shares issued and multiply it by PDS Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PDS Biotechnology Corp classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 28.89 M outstanding shares.
PDS Biotechnology Corp has accumulated about 74.75 M in cash with (12.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PDS Biotechnology Probability Of Bankruptcy
Ownership AllocationPDS Biotechnology owns a total of 28.89 Million outstanding shares. PDS Biotechnology holds 14.2 pct. of its outstanding shares held by insiders and 23.77 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PDS Ownership Details
PDS Biotechnology Corp Risk Profiles
Although PDS Biotechnology's alpha and beta are two of the key measurements used to evaluate PDS Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.06 | |||
| Standard Deviation | 5.78 | |||
| Variance | 33.4 | |||
| Risk Adjusted Performance | (0.08) |
PDS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in PDS Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
PDS Biotechnology Corporate Management
Elected by the shareholders, the PDS Biotechnology's board of directors comprises two types of representatives: PDS Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PDS. The board's role is to monitor PDS Biotechnology's management team and ensure that shareholders' interests are well served. PDS Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PDS Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Otis Brawley | Director | Profile | |
| Joe Dervan | VP RD | Profile | |
| Deanne Randolph | VP Relations | Profile | |
| Gregory Conn | Chief Scientific Officer | Profile | |
| Spencer JD | Sr Counsel | Profile | |
| Nathalie Riebel | VP Operations | Profile | |
| Janetta Trochimiuk | Controller | Profile |
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.